Posts by MD Pharma Consulting Group
Insulin Resistance – What does it mean?
Insulin sensitivity and insulin resistance are trending hot topics! Here are some interesting facts about glucose metabolism, insulin sensitivity, and insulin resistance: 1. Digestive enzymes break down food into smaller particles and nutrient molecules to be absorbed by the gastrointestinal tract. 2. Carbohydrates are broken into monosaccharide molecules called glucose molecules. 3. Glucose is an…
Read More5-minute weekly newscast – 23/06/2019
The spotlight is on the researchers at Rice University and the University of Washington. They have 3D-bioprinted a live lung model! This is a major breakthrough in 3D-bioprinting and bioengineering. The major challenge facing 3D-bioprinting of any live organ model is keeping the 3D-bioprinted organs alive. With the 3D-bioprinted live lung model, scientists have to…
Read More5-minute weekly newscast – 16/06/2019
The spotlight is on you. Three weeks ago, everyone was scrutinizing President Donald Trump’s executive order authorizing disclosure of costs across the healthcare industry including drug prices. Literally everyone, politicians, trade groups, lobbyists, and even doctors! But no one asked what do the patients think? According to a survey by WeGo Health, 70% of patient…
Read More5-minute weekly newscast – 09/06/2019
The spotlight is on Sanofi Pasteur. The French pharma giant is heading for management shuffle as Sanofi CEO Olivier Brandicourt retires on September 1st, 2019, and Paul Hudson—former president of Novartis’ pharma business—steps in as Sanofi’s new CEO. Hamilton Company and Enable Biosciences have announced their collaboration to provide Hamilton’s Microlab® STAR™ fully automated workstation optimized to work…
Read More5-minute weekly newscast – 02/06/2019
The spotlight is on the 2019 ASCO annual meeting. The meeting is due on Friday May 31, 2019 to Tuesday June 4, 2019 at McCormick Place, Chicago, Illinois. The meeting will feature the latest advances in cancer R&D including Merck & Co. immuno-oncology star Keytruda, Novartis’ Kisqali, Pfizer blockbuster Ibrance, AstraZeneca and Merck’s Lynparza, Pfizer…
Read More5-minute weekly newscast – 26/05/2019
The spotlight is on President Donald Trump who will sign an executive order within the next few days authorizing disclosure of costs across the healthcare industry including drug prices. Big Data and advanced data analytics are revolutionizing the industry. Circuit Clinical, an American based patient-oriented integrated research organization, announced partnership with Calspan-University of Buffalo Research…
Read MoreRecent Advances in Treatment of Stage IV Metastatic Breast Cancer
Breast cancer is the most common cancer type in women worldwide. It is estimated that 70% of patients with breast cancer are estrogen receptor (ER)-positive, making hormonal therapies using ER antagonists and degraders, such as tamoxifen and fulvestrant, common treatments for breast cancer. However, therapies with ER-independent mechanisms are needed as approximately 30% of breast…
Read More5-minute weekly newscast – 19/05/2019
The spotlight is on Gilead, a market leader in HIV treatment, who shared the promising news of donating 2.4 million bottles of Truvada to help ending the HIV epidemic in the United States. Astra Zeneca is implementing artificial intelligence and machine learning for the discovery and development of new treatments for chronic kidney disease and idiopathic pulmonary…
Read MoreRecent Advances in Treatment of Stage IV Metastatic Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Approximately 40% of NSCLC patients are diagnosed with stage IV after the tumor has metastasized. As NSCLC is less sensitive to chemotherapy compared to small cell lung cancer (SCLC), research focus has focused on the development of immunotherapies using monoclonal antibodies (mABs).…
Read MoreChoosing the Right Immunoassays for Your Radiobiology Experiments
Radiation therapy is one of the most common treatments for cancer. In order to improve the treatment efficacy of radiation therapies, radiobiology is the field of basic research that studies the cellular and molecular biological factors influencing the response of cancerous and normal cell lines to ionizing radiation. In a typical radiobiology experiment, a cell…
Read More